Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$98.98 - $115.74 $80,866 - $94,559
-817 Reduced 3.16%
25,059 $2.9 Million
Q2 2023

Aug 14, 2023

BUY
$96.34 - $112.38 $2.49 Million - $2.91 Million
25,876 New
25,876 $2.66 Million
Q4 2022

Feb 14, 2023

BUY
$62.39 - $113.8 $320,247 - $584,135
5,133 Added 19.27%
31,776 $3.62 Million
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $443,137 - $636,803
7,521 Added 39.33%
26,643 $1.65 Million
Q2 2022

Aug 22, 2022

SELL
$79.4 - $116.36 $189,607 - $277,867
-2,388 Reduced 11.1%
19,122 $1.53 Million
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $832,570 - $1.06 Million
9,634 Added 81.12%
21,510 $2.26 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $131,577 - $160,079
1,335 Added 12.66%
11,876 $1.28 Million
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $974,154 - $1.17 Million
-10,599 Reduced 50.14%
10,541 $1.16 Million
Q2 2021

Aug 12, 2021

SELL
$86.24 - $95.92 $104,954 - $116,734
-1,217 Reduced 5.44%
21,140 $1.98 Million
Q1 2021

May 17, 2021

BUY
$71.83 - $95.48 $45,612 - $60,629
635 Added 2.92%
22,357 $2.06 Million
Q4 2020

Feb 12, 2021

BUY
$67.0 - $84.39 $151,487 - $190,805
2,261 Added 11.62%
21,722 $1.59 Million
Q3 2020

Nov 13, 2020

SELL
$55.23 - $79.93 $192,918 - $279,195
-3,493 Reduced 15.22%
19,461 $1.51 Million
Q2 2020

Aug 14, 2020

BUY
$30.2 - $56.98 $477,311 - $900,568
15,805 Added 221.08%
22,954 $1.28 Million
Q1 2020

May 14, 2020

SELL
$24.87 - $38.56 $64,487 - $99,986
-2,593 Reduced 26.62%
7,149 $258,000
Q4 2019

Feb 13, 2020

BUY
$25.43 - $36.67 $7,018 - $10,120
276 Added 2.92%
9,742 $353,000
Q3 2019

Nov 13, 2019

BUY
$23.0 - $27.97 $4,278 - $5,202
186 Added 2.0%
9,466 $241,000
Q2 2019

Aug 14, 2019

BUY
$22.81 - $28.48 $211,676 - $264,294
9,280 New
9,280 $223,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.